AstraZeneca AB et al v. Alembic Pharmaceuticals Ltd. et al
| AstraZeneca Pharmaceuticals LP and AstraZeneca AB |
| Alembic Pharmaceuticals, Inc. and Alembic Pharmaceuticals Ltd. |
| 1:2021cv00875 |
| June 18, 2021 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 9, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
SO ORDERED, re #14 STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Alembic Pharmaceuticals Ltd. answer due 9/10/2021; Alembic Pharmaceuticals, Inc. answer due 9/10/2021). Signed by Judge Richard G. Andrews on 8/9/2021. (nms)
|
| Filing 14 STIPULATION TO EXTEND TIME for Defendants to Answer, Move or Otherwise Respond to Complaint to September 10, 2021 - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Joyce, Alexandra) |
|
SO ORDERED, re #13 STIPULATION and Proposed Order (*Reset Answer Deadlines: Alembic Pharmaceuticals Ltd. answer due 8/11/2021; Alembic Pharmaceuticals, Inc. answer due 8/11/2021). Signed by Judge Richard G. Andrews on 7/19/2021. (nms)
|
| Filing 13 STIPULATION and Proposed Order extending time to answer, move, or otherwise respond to Plaintiffs Complaint to August 11, 2021 - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) Modified on 7/19/2021 (nms). |
| Filing 12 STATUS REPORT, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) Modified on 7/19/2021 (nms). |
|
Filing 11
ORAL ORDER: An answer was due to be filed on 7/12/2021 (see D.I. #8 ), and to date none has been filed. A status letter is now due no later than 3 days from the entry of this Order. Ordered by Judge Richard G. Andrews on 7/15/2021. (nms)
|
| Filing 10 MOTION for Pro Hac Vice Appearance of Attorney Ryan P. O'Quinn and Mark J. Feldstein - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: #1 Certifications for Ryan P. O'Quinn and Mark J. Feldstein)(Silver, Daniel) |
|
SO ORDERED, re #10 MOTION for Pro Hac Vice Appearance of Attorney Ryan P. O'Quinn and Mark J. Feldstein, filed by AstraZeneca Pharmaceuticals LP, AstraZeneca AB. Signed by Judge Richard G. Andrews on 6/23/2021. (nms)
|
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Filing 9 DECLARATION of Service for Defendant Alembic Pharmaceuticals Ltd. made on June 21, 2021, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: #1 Exhibits A-B)(Joyce, Alexandra) Modified on 6/23/2021 (nms). |
| Filing 8 SUMMONS Returned Executed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. Alembic Pharmaceuticals, Inc. served on 6/21/2021, answer due 7/12/2021. (Joyce, Alexandra) |
| Filing 7 Summonses Issued (please complete the top portion of the form and print out for use/service). (mal) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca Pharmaceuticals LP filed by AstraZeneca Pharmaceuticals LP. (mal) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB filed by AstraZeneca AB. (mal) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,425,934 ;10,300,065. (mal) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No Earlier than May 7, 2021. Date of Expiration of Patent: 4/17/2030 (8,425,934) and 1/27/2036 (10,300,065).Thirty Month Stay Deadline: No earlier than 11/7/2023. (mal) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT - filed against Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3638657.) - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: #1 Exhibit A-B, #2 Civil Cover Sheet)(mal) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
